These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 9448481)

  • 41. The application of the precautionary principle to the blood system: the Canadian blood system's vCJD donor deferral policy.
    Wilson K; Wilson M; Hébert PC; Graham I
    Transfus Med Rev; 2003 Apr; 17(2):89-94. PubMed ID: 12733102
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Managing the risk of transmission of variant Creutzfeldt Jakob disease by blood products.
    Ludlam CA; Turner ML
    Br J Haematol; 2006 Jan; 132(1):13-24. PubMed ID: 16371015
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cost-effectiveness of prion filtration of red blood cells to reduce the risk of transfusion-transmitted variant Creutzfeldt-Jakob disease in the Republic of Ireland.
    Teljeur C; Flattery M; Harrington P; O'Neill M; Moran PS; Murphy L; Ryan M
    Transfusion; 2012 Nov; 52(11):2285-93. PubMed ID: 22486387
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Can CJD be transmitted through the blood supply?
    Giulivi A
    CMAJ; 1998 Mar; 158(6):714; author reply 715-7. PubMed ID: 9538847
    [No Abstract]   [Full Text] [Related]  

  • 45. Creutzfeldt-Jakob disease and blood transfusion.
    Fernandez Lopez MJ; Van Everbroeck B; Pals P; Martin JJ; Cras P
    Acta Neurol Belg; 1998 Sep; 98(3):247-51. PubMed ID: 9801705
    [TBL] [Abstract][Full Text] [Related]  

  • 46. NBA/NBS perspective on nvCJD.
    Wallington T
    Transfus Sci; 1998 Dec; 19(4):329-30. PubMed ID: 10351146
    [No Abstract]   [Full Text] [Related]  

  • 47. Infectivity in the blood of mice with a BSE-derived agent.
    Taylor DM; Fernie K; Reichl HE; Somerville RA
    J Hosp Infect; 2000 Sep; 46(1):78-9. PubMed ID: 11023729
    [No Abstract]   [Full Text] [Related]  

  • 48. Creutzfeldt-Jakob disease: reflections on the risk from blood product therapy.
    Brown P
    Haemophilia; 2007 Dec; 13 Suppl 5():33-40. PubMed ID: 18078395
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Can CJD be transmitted through the blood supply.
    Larke B
    CMAJ; 1998 Mar; 158(6):714-5. PubMed ID: 9538848
    [No Abstract]   [Full Text] [Related]  

  • 50. World Health Organization consultation on public health issues related to bovine spongiform encephalopathy and the emergence of a new variant of Creutzfeldt-Jakob disease.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1996 Apr; 45(14):295-6, 303. PubMed ID: 8598828
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The success of precaution? Managing the risk of transfusion transmission of variant Creutzfeldt-Jakob disease.
    Wilson K; Ricketts MN
    Transfusion; 2004 Oct; 44(10):1475-8. PubMed ID: 15383021
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The impact of improved safety on maintaining a sufficient blood supply.
    Reynolds E; Wickenden C; Oliver A
    Transfus Clin Biol; 2001 Jun; 8(3):235-9. PubMed ID: 11499967
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Much news on the prion front].
    Norrby E
    Lakartidningen; 2010 May 5-11; 107(18):1218-24. PubMed ID: 20521593
    [No Abstract]   [Full Text] [Related]  

  • 54. New insights into Creutzfeldt-Jakob disease.
    Wood HB
    Nat Clin Pract Neurol; 2006 Jun; 2(6):287. PubMed ID: 16932566
    [No Abstract]   [Full Text] [Related]  

  • 55. [Legal obligation to inform the patient on the theoretical risk of CJD transmission by blood].
    Boixière A; Hergon E; Moutel G; Rouger P; Hervé C
    Transfus Clin Biol; 2004 Apr; 11(2):101-5. PubMed ID: 15120108
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Creutzfeldt-Jakob disease.
    Clement P
    Haemophilia; 2000 Jul; 6 Suppl 1():68-78. PubMed ID: 10982271
    [No Abstract]   [Full Text] [Related]  

  • 57. The sensibility of safety: reflections on the Krever inquiry's final report.
    Hoey J
    CMAJ; 1998 Jan; 158(1):59-60. PubMed ID: 9475910
    [No Abstract]   [Full Text] [Related]  

  • 58. A third episode of transfusion-derived vCJD.
    Wilson K; Ricketts MN
    Lancet; 2006 Dec; 368(9552):2037-9. PubMed ID: 17161714
    [No Abstract]   [Full Text] [Related]  

  • 59. WHO reconsiders risks from Creutzfeldt-Jakob disease.
    Morris K
    Lancet; 1997 Apr; 349(9057):1001. PubMed ID: 9132515
    [No Abstract]   [Full Text] [Related]  

  • 60. The impact of new-variant Creutzfeldt-Jakob disease on blood transfusion practice.
    Turner M
    Br J Haematol; 1999 Sep; 106(4):842-50. PubMed ID: 10519983
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.